04. NEVA SPECIFICATIONS SHEET
To be used for tenders as needed.
03. NEVA CUSTOMER PRESENTATION
Includes design goals, features and benefits, clinical evidence, tips & tricks on how to maximize the Drop Zone impact. Contact Market Development for the PowerPoint version and for help in organizing a NeVa Induction Webinar if needed.
02. NEVA PRODUCT BROCHURE
Product brochure to be used as leave behind piece as needed. This document includes only NeVa codes.
Vesalio Neva Branding Resources
Brand guidelines to show the Vesalio brand is to be used and presented to the public.
Vesalio Secures Class A Funding
Vesalio announces it has successfully secured a Class A financing round. The proceeds will be utilized to support the ongoing US IDE stroke study, establish US infrastructure, expand its innovative product portfolio, and scale international business.
Vesalio Initiates FDA IDE Stroke Study
Vesalio announces another key milestone to support entry into the US neurovascular thrombectomy market. Enrollment has commenced in the Vesalio CLEAR acute ischemic stroke FDA IDE clinical trial utilizing the NeVaTM thrombectomy technology platform.
Vesalio Attains Key FDA Clinical Study Milestone
Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL 1 clinical trial, assessing the company’s NeVa VS™ technology in the treatment of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH), has been completed.
Vesalio Receives Peripheral FDA 510k Clearance and Additional CE Approval
Vesalio reports it has obtained an FDA 510k clearance and its 4th CE approval. The FDA 510k indication is for the removal of thrombi in peripheral blood vessels.
Vesalio Reports 2,500 Patient Milestone
Vesalio reports it has surpassed 2,500 clinical cases with the NeVa™ neuro-thrombectomy platform. Physicians have evaluated the Neva Drop Zone™ technology with enthusiasm as it has shown a unique capability of removing the full spectrum of clot types in large vessel occlusion ischemic stroke.
Initiates Virtual Training and Announces Pass Effect Rate Publication
Vesalio announces it has executed additional exclusive distribution agreements in Europe, Latin America, Asia, and the Middle East. With these new partnerships, the NeVa™ Thrombectomy System has gained market coverage in 53 countries.
